DK0670892T3 - Rensning, sammensætning og specificitet af heparinase I, II og III fra Flavobacterium heparinum - Google Patents

Rensning, sammensætning og specificitet af heparinase I, II og III fra Flavobacterium heparinum

Info

Publication number
DK0670892T3
DK0670892T3 DK94902450T DK94902450T DK0670892T3 DK 0670892 T3 DK0670892 T3 DK 0670892T3 DK 94902450 T DK94902450 T DK 94902450T DK 94902450 T DK94902450 T DK 94902450T DK 0670892 T3 DK0670892 T3 DK 0670892T3
Authority
DK
Denmark
Prior art keywords
heparinase
specificity
purification
iii
composition
Prior art date
Application number
DK94902450T
Other languages
English (en)
Inventor
Ramnath Sasisekharan
Daniel L Lohse
Charles L Cooney
Robert J Linhardt
Robert S Langer
Original Assignee
Massachusetts Inst Technology
Univ Iowa Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology, Univ Iowa Res Found filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of DK0670892T3 publication Critical patent/DK0670892T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/85—Flavobacterium

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK94902450T 1992-11-30 1993-11-30 Rensning, sammensætning og specificitet af heparinase I, II og III fra Flavobacterium heparinum DK0670892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/983,367 US5389539A (en) 1992-11-30 1992-11-30 Purification of heparinase I, II, and III from Flavobacterium heparinum
PCT/US1993/011541 WO1994012618A1 (en) 1992-11-30 1993-11-30 PURIFICATION, COMPOSITION AND SPECIFICITY OF HEPARINASE I, II, AND III FROM $i(FLAVOBACTERIUM HEPARINUM)

Publications (1)

Publication Number Publication Date
DK0670892T3 true DK0670892T3 (da) 2005-08-15

Family

ID=25529915

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94902450T DK0670892T3 (da) 1992-11-30 1993-11-30 Rensning, sammensætning og specificitet af heparinase I, II og III fra Flavobacterium heparinum

Country Status (10)

Country Link
US (4) US5389539A (da)
EP (1) EP0670892B1 (da)
JP (3) JPH08505767A (da)
AT (1) ATE298366T1 (da)
CA (1) CA2150263C (da)
DE (1) DE69333834T2 (da)
DK (1) DK0670892T3 (da)
ES (1) ES2243924T3 (da)
PT (1) PT670892E (da)
WO (1) WO1994012618A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389539A (en) 1992-11-30 1995-02-14 Massachusetts Institute Of Technology Purification of heparinase I, II, and III from Flavobacterium heparinum
US5681733A (en) * 1994-06-10 1997-10-28 Ibex Technologies Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum
US5997863A (en) * 1994-07-08 1999-12-07 Ibex Technologies R And D, Inc. Attenuation of wound healing processes
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
CA2235223A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
US6458574B1 (en) 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
JP2003527822A (ja) * 1998-08-27 2003-09-24 マサチューセッツ インスティテュート オブ テクノロジー ヘパリナーゼｉおよびｉｉ由来の合理的に設計されたヘパリナーゼ
WO2000065521A2 (en) * 1999-04-23 2000-11-02 Massachusetts Institute Of Technology System and method for polymer notation
WO2001066772A2 (en) * 2000-03-08 2001-09-13 Massachusetts Institute Of Technology Heparinase iii and uses thereof
CA2422059C (en) 2000-09-12 2012-05-15 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
CA2423469A1 (en) * 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
KR20020046293A (ko) * 2000-12-12 2002-06-21 김영식 글리코사미노글리칸을 분해하는 인간 장내 미생물 유래신규 헤파리네이즈, 그의 제조 방법 및 용도
US20030219854A1 (en) * 2002-03-21 2003-11-27 Micrologix Biotech Inc. Methods for producing modified anti-infective peptides
WO2003102160A2 (en) * 2002-06-03 2003-12-11 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from chondroitinase b
US20040265943A1 (en) * 2002-09-23 2004-12-30 Aventis Pharma S.A. Method for quantitatively determining specific groups constituting heparins or low molecular weight heparins
FR2844808B1 (fr) * 2002-09-23 2005-02-25 Aventis Pharma Sa Methode de determination de groupements specifiques constituant les heparines ou les heparines de bas poids moleculaire
JP4773976B2 (ja) * 2004-01-30 2011-09-14 エモリー ユニバーシティ 神経再生を促進する材料および方法
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
US7767420B2 (en) 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
CN104593347B (zh) * 2015-03-05 2018-08-28 深圳市海普瑞药业集团股份有限公司 来自Sphingobacterium daejeonense的肝素酶及其制备和应用
CN114787195B (zh) * 2019-12-27 2024-01-12 深圳市天道医药有限公司 一种肝素酶iii的制备方法
CN113046358A (zh) * 2021-03-10 2021-06-29 华侨大学 一种重组鱼精蛋白专用编码基因和制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54107584A (en) * 1978-02-10 1979-08-23 Seikagaku Kogyo Co Ltd Preparation of pure heparinase
IL61201A (en) 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
IT1141249B (it) 1980-02-28 1986-10-01 Italfarmaco Spa Procedimento per la preparazione di copolimeri di polisaccaridi supprotanti attivita' enzimatica,e copolimeri cosi' ottenuti
US4443545A (en) * 1980-08-25 1984-04-17 Massachusetts Institute Of Technology Process for producing heparinase
US4341869A (en) * 1980-08-25 1982-07-27 Massachusetts Institute Of Technology Process for producing heparinase
US4373023A (en) * 1980-10-14 1983-02-08 Massachusetts Institute Of Technology Process for neutralizing heparin
US4396762A (en) * 1981-08-24 1983-08-02 Massachusetts Institute Of Technology Heparinase derived anticoagulants
US4847338A (en) 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
FR2584728B1 (fr) 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US4795703A (en) 1986-03-07 1989-01-03 The Children's Medical Center Corporation Heparin assay
US4885207A (en) 1987-07-13 1989-12-05 Uop Biocompatible protein or ligand immobilization system
ATE113991T1 (de) * 1988-06-06 1994-11-15 Massachusetts Inst Technology Verfahren zur reinigung hochreiner heparinase in grosser menge.
US5169772A (en) * 1988-06-06 1992-12-08 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase from flavobacterium heparinum
JP2726275B2 (ja) * 1988-08-24 1998-03-11 生化学工業株式会社 グリコサミノグリカン分解酵素の精製法
JP2833793B2 (ja) 1989-09-19 1998-12-09 科学技術振興事業団 ヘパリナーゼをコードするプラスミド、このプラスミドを保持するヘパリナーゼ生産株及びヘパリナーゼの製造法
JP3108486B2 (ja) 1991-11-19 2000-11-13 古河電気工業株式会社 セラミックス超電導導体
US5389539A (en) 1992-11-30 1995-02-14 Massachusetts Institute Of Technology Purification of heparinase I, II, and III from Flavobacterium heparinum

Also Published As

Publication number Publication date
DE69333834T2 (de) 2006-06-01
JP2004135684A (ja) 2004-05-13
USRE41328E1 (en) 2010-05-11
ES2243924T3 (es) 2005-12-01
JPH08505767A (ja) 1996-06-25
US5569600A (en) 1996-10-29
WO1994012618A1 (en) 1994-06-09
EP0670892B1 (en) 2005-06-22
US5389539A (en) 1995-02-14
JP2005278651A (ja) 2005-10-13
USRE41461E1 (en) 2010-07-27
EP0670892A4 (en) 1997-05-28
ATE298366T1 (de) 2005-07-15
EP0670892A1 (en) 1995-09-13
DE69333834D1 (de) 2005-07-28
CA2150263A1 (en) 1994-06-09
CA2150263C (en) 1998-08-04
PT670892E (pt) 2005-11-30

Similar Documents

Publication Publication Date Title
DK0670892T3 (da) Rensning, sammensætning og specificitet af heparinase I, II og III fra Flavobacterium heparinum
EA199900678A1 (ru) Производные амида гетероарил-гексановой кислоты, их получение и их применение в качестве селективных ингибиторов связывания mip-1-альфа с его рецептором ccr1
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
FI931370A0 (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
EA200200590A1 (ru) Производные пирролидина в качестве ингибиторов фосфодиэстеразы, специфичной к циклическому амф
WO1993000330A3 (en) Azanorbornane derivatives
NO992353L (no) Rensing av neurotrofiner
NO863495L (no) Fremgangsmaate ved utskillelse av c2-hydrocarboner fra jordgass.
DK245284D0 (da) Fremgangsmaade til biologisk afsvovling af kul,samt fremgangsmaade til selektiv fremstilling af mikroorganismer til odoevelse heraf
NO870643L (no) Fraksjoneringssystem for separering av nitrogen fra naturgass med variabelt nitrogeninnhold.
DK415285D0 (da) Fremgangsmaade til separation af naturgasvaesker fra nitrogenholdig naturgas
NO933146L (no) Fremgangsmåte ved undersökelse av Lupus antikoagulerende middel
ATE429486T1 (de) Expansionskulturverfahren für antigenspezifische zytotoxische t-lymphozyten
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
EA199900511A1 (ru) N-связанные мочевины и карбаматы сложных гетероциклических тиоэфиров
IT1207057B (it) Policarbonati ramificati contenenti 2,4,6-tris(4'-idrossiaril)-ammino-s-triazine.
DK191588A (da) Apparat til katalytisk fjernelse af nitrogenforbindelser fra roeggas
NO980376L (no) Rengjörende blanding omfattende en alifatisk hydrokarbonforbindelse med minst to aromatiske substituenter
DK0549525T3 (da) Monoklone antistoffer mod sulfonylurinstofherbicider samt deres anvendelse til påvisning
ES2001564A6 (es) Procedimiento para la obtencion de tiazolilalquil y tienilalquilesteres de los acidos alfa-imidazolinon nicotinicos y benzoicos
IT1188905B (it) Procedimetno per la produzione di carburo di calcio e gas acetilenico combustibile ottenuto da detto carburo
ATE28200T1 (de) Spiro(benzofuran-azalkane), eine methode zu deren herstellung und ihre verwendung als medikamente.
NO953060L (no) Forbedret fremgangsmåte for isolering av cefaclor etter enzymatisk acylering
Nelson et al. Anilinonaphthalene sulfonate isomers inactivate phosphoenolpyruvate carboxykinase
IE44907L (en) Purification of heparin